Clinical Neurogenetics

71 – 80 of 91

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/v1001114?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
6
7
8
9
10
next »

2016
Mark Wilson disease: Acute dystonia during treatment with SSRI or SNRI
Wictor, Lars ^LU ; Wictorin, Klas ^LU ; Widner, Håkan ^LU and Puschmann, Andreas ^LU (2016) XXI World Congress on Parkinson's Disease and Related Disorders In Parkinsonism and Related Disorders 22(Suppl 2). p.140-141
- Contribution to journal › Published meeting abstract
Mark Tobacco increases dystonia risk but may ameliorate symptoms
Hellberg, Clara ^LU and Puschmann, Andreas ^LU (2016) XXI World Congress on Parkinson's Disease and Related Disorders In Parkinsonism and Related Disorders 22(Suppl 2). p.137-138
- Contribution to journal › Published meeting abstract
Mark ¹⁸F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
Smith, Ruben ^LU ; Puschmann, Andreas ^LU ; Schöll, Michael ^LU ; Ohlsson, Tomas ; Van Swieten, John ; Honer, Michael ; Englund, Elisabet ^LU and Hansson, Oskar ^LU (2016) In Brain 139(9). p.2372-2379
- Contribution to journal › Article
Mark Loci associated with ischaemic stroke and its subtypes (SiGN): A genome-wide association study
Pulit, Sara L ; Delavaran, Hossein ^LU ; Engström, Gunnar ^LU ; Ilinca, Andreea ^LU ; Melander, Olle ^LU ; Lindgren, Arne ^LU ; Söderholm, Martin ^LU and Worrall, Bradford (2016) In The Lancet Neurology 15(2). p.174-184
- Contribution to journal › Article
2015
Mark CHCHD2 and Parkinson's disease
Puschmann, Andreas ^LU ; Dickson, Dennis W ; Englund, Elisabet ^LU ; Wszolek, Zbigniew K and Ross, Owen A (2015) In Lancet Neurology 14(7). p.679-679
- Contribution to journal › Letter
Mark Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statement.
Puschmann, Andreas ^LU ; Brighina, Laura ; Markopoulou, Katerina ; Aasly, Jan ; Chung, Sun Ju ; Frigerio, Roberta ; Hadjigeorgiou, Georgios ; Kõks, Sulev ; Krüger, Rejko and Siuda, Joanna , et al. (2015) In Parkinsonism & Related Disorders 21(7). p.675-682
- Contribution to journal › Article
Mark Clinical Correlations With Lewy Body Pathology in LRRK2-Related Parkinson Disease.
Kalia, Lorraine V ; Lang, Anthony E ; Hazrati, Lili-Naz ; Fujioka, Shinsuke ; Wszolek, Zbigniew K ; Dickson, Dennis W ; Ross, Owen A ; Van Deerlin, Vivianna M ; Trojanowski, John Q and Hurtig, Howard I , et al. (2015) In JAMA Neurology 72(1). p.100-105
- Contribution to journal › Article
Mark Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C : an observational cohort study
Patterson, Marc C. ; Mengel, Eugen ; Vanier, Marie T. ; Schwierin, Barbara ; Muller, Audrey ; Cornelisse, Peter ; Pineda, Mercè ; Puschmann, Andreas ^LU and Rask, Olof ^LU (2015) In Orphanet Journal of Rare Diseases 10. p.65-65
- Contribution to journal › Article
Mark Large-scale assessment of polyglutamine repeat expansions in Parkinson disease
Wang, Lisa and Sharma, Manu (2015) In Neurology 85(15). p.92-1283
- Contribution to journal › Article
2014
Mark Atypical Friedreich ataxia in patients with FXN p.R165P point mutation or comorbid hemochromatosis.
YGLAND, EMIL ^LU ; Taroni, Franco ; Gellera, Cinzia ; Caldarazzo, Serena ; Duno, Morten ; Soller, Maria ^LU and Puschmann, Andreas ^LU (2014) In Parkinsonism & Related Disorders 20(8). p.919-923
- Contribution to journal › Article

« previous
1
…
6
7
8
9
10
next »